Reduced regulatory T cells (Treg) in bone marrow preferentially associate with the expansion of cytotoxic T lymphocytes in low risk MDS patients-Reference-Cited by-同舟云学术

Reduced regulatory T cells (Treg) in bone marrow preferentially associate with the expansion of cytotoxic T lymphocytes in low risk MDS patients

Published:2018-07-16 Issue:2 Volume:185 Page:357-360
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Giovazzino Angela¹,Leone Stefania²,Rubino Valentina¹³,Palatucci Anna Teresa¹⁴,Cerciello Giuseppe²,Alfinito Fiorella²,Pane Fabrizio²,Ruggiero Giuseppina¹^ORCID,Terrazzano Giuseppe¹³

Affiliation:

1. Dipartimento di Scienze Mediche Traslazionali Università di Napoli “Federico II” NapoliItaly

2. Dipartimento di Medicina Clinica e Chirurgia Università di Napoli “Federico II” NapoliItaly

3. Dipartimento di Scienze Università della Basilicata PotenzaItaly

4. Istituto per l'Endocrinologia e l'Oncologia Sperimentale Consiglio Nazionale delle Ricerche (IEOS‐CNR)Napoli Italy

Funder

Fondazione Italiana Sclerosi Multipla

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15496

Reference10 articles.

1. Myelodysplastic syndromes

2. Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes

3. Immune Mechanisms in Myelodysplastic Syndrome

4. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

5. Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium;HemaSphere;2024-05

2. T-cell dysfunctions in myelodysplastic syndromes;Blood;2024-04-04

3. Regulatory TR3-56 Cells in the Complex Panorama of Immune Activation and Regulation;Cells;2023-12-15

4. Diagnostic and prognostic value of ferroptosis-related genes in patients with Myelodysplastic neoplasms;Hematology;2023-12

5. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease;International Journal of Molecular Sciences;2023-05-31